| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| FOSL2 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0478.1
...
|
| FOSL2 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0478.1
...
|
| FOSL2 |
A549 (lung carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR593DGU
|
MA0478.1
...
|
| FOSL2 |
LPS141 (Dedifferentiated liposarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE111253
...
|
MA0478.1
...
|
| FOSL2 |
hESC-1 (Embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE69539
|
MA0478.1
|
| FOXA1 |
A549 (lung carcinoma) |
1 h with 100 nM Dexamethasone (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BPX
|
MA0148.4
|
| FOXA1 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BRD
|
MA0148.4
|
| FOXA1 |
lung adenocarcinoma |
Nkx2-1 negative |
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
| FOXA1 |
lung adenocarcinoma |
Nkx2-1 negative |
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
| FOXA1 |
intestinal villus epithelial cells |
Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background; |
Permissive
Robust
|
Mus musculus |
GSE111024
...
|
MA0148.4
|
Showing 10 records in page 39
from 195 pages